METASTATIC UVEAL MELANOMA
Clinical trials for METASTATIC UVEAL MELANOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC UVEAL MELANOMA trials appear
Sign up with your email to follow new studies for METASTATIC UVEAL MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo shows promise against rare eye cancer
Disease control CompletedThis study tested whether combining two immunotherapy drugs, nivolumab and relatlimab, could shrink tumors in people with metastatic uveal melanoma, a rare eye cancer that has spread. 27 adults who had not received certain prior treatments took part. The goal was to see how many …
Matched conditions: METASTATIC UVEAL MELANOMA
Phase: PHASE2 • Sponsor: Jose Lutzky, MD • Aim: Disease control
Last updated May 17, 2026 03:18 UTC
-
Liver-Directed immune therapy shows promise in advanced melanoma
Disease control CompletedThis early-phase study tested a treatment where a patient's own immune cells (called tumor-infiltrating lymphocytes) are grown in a lab and then infused directly into the liver artery. The goal was to see if this approach is safe and feasible for people with melanoma that has spr…
Matched conditions: METASTATIC UVEAL MELANOMA
Phase: PHASE1 • Sponsor: Vastra Gotaland Region • Aim: Disease control
Last updated May 17, 2026 03:12 UTC
-
New tool aims to ease tough talks on cancer resistance
Knowledge-focused CompletedThis study aimed to create a communication tool to help doctors and patients talk about cancer that stops responding to treatment. Researchers interviewed 128 people, including patients with certain breast cancers, metastatic uveal melanoma, and parents of children with cancer, a…
Matched conditions: METASTATIC UVEAL MELANOMA
Phase: NA • Sponsor: Institut Curie • Aim: Knowledge-focused
Last updated May 13, 2026 15:59 UTC